Chapter Opt 6

USE OF DIAGNOSTIC AND THERAPEUTIC PHARMACEUTICAL AGENTS AND REMOVAL OF SUPERFICIAL FOREIGN BODIES FROM AN EYE OR FROM AN APPENDAGE TO THE EYE

Opt 6.01   Authority.

Opt 6.02   Definitions.

Opt 6.025   Adverse drug reaction referral plan.

Opt 6.03   Certificate to use diagnostic pharmaceutical agents.

Opt 6.04   Certificate to use therapeutic pharmaceutical agents and remove foreign bodies from eyes.

Opt 6.05   Prescribing therapeutic pharmaceutical agents.

Opt 6.01 Opt 6.01 Authority. The rules in this chapter are adopted under authority in ss. 15.08 (5) (b), 227.11 (2), 449.17, 449.18, and 961.39, Stats.

Opt 6.01 Note Note: The rules in this chapter apply only to optometrists licensed by the State of Wisconsin in accordance with ch. Opt 3 or ch. Opt 4, as applicable.

Opt 6.01 Note Note: To determine which pharmaceutical agents may be used by licensed optometrists, refer to ch. SPS 10, relating to the use of pharmaceutical agents by licensed optometrists.

Opt 6.01 History History: Cr. Register, December, 1990, No. 420, eff. 1-1-91; CR 06-116: am. Register May 2007 No. 617, eff. 6-1-07; CR 19-027: am. Register January 2020 No. 769, eff. 2-1-20.

Opt 6.02 Opt 6.02 Definitions. In this chapter:

Opt 6.02(1) (1) “Adverse drug reaction” means an adverse, physical or psychological reaction experienced by a person resulting from diagnostic or therapeutic pharmaceutical agents administered by an optometrist that occurs within 24 hours after the drug is administered. An “adverse drug reaction” may be indicated by symptoms that include any of the following:

Opt 6.02(1)(a) (a) Red eye.

Opt 6.02(1)(b) (b) Painful eye.

Opt 6.02(1)(c) (c) Decrease in vision.